Cancer Center Amsterdam

Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial

Seefat, M. R., van der Maas, N. G., Nasserinejad, K., van der Holt, B., Waage, A., Mellqvist, U.-H., Vangsted, A. J., Smit, A. J. T., Smits, F., Ypma, P. F., van de Donk, N. W. C. J., Blommestein, H. M., Cornelissen, J. J., Cucchi, D. G. J., Zweegman, S. & Versluis, J., 2025, (E-pub ahead of print) In: EClinicalMedicine. 103605.

Research output: Contribution to journal › Article › Academic › peer-review

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma

Seefat, M. R., Cucchi, D. G. J., van Boven, L., Durdu-Rayman, N., Groen, K., Levin, M. D., de Heer, K., de Valk, B., Wester, R., van der Spek, E., Rentenaar, R., Korst, C. L. B. M., Quik, M., O'Neill, C. A., Tzortzi, P., Smits, F., Mathot, R., Heerma van Voss, M. R., van de Donk, N. W. C. J. & Mutis, T. & 2 others, Bartelink, I. H. & Zweegman, S., 2025, (E-pub ahead of print) In: British Journal of Haematology.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial

Seefat, M. R., Stege, C. A. M., Lissenberg-Witte, B. I., Levin, M. D., Timmers, G. J., Hoogendoorn, M., Ypma, P. F., Klein, S. K., Velders, G. A., Westerman, M., Strobbe, L., Durdu-Rayman, N., Davidis-van Schoonhoven, M. A., van Kampen, R. J. W., Dijk, A. C., Koster, A., Silbermann, M. H., van der Spek, E., Beeker, A. & Erjavec, Z. & 8 others, de Graauw, N. C. H. P., Leys, M. B. L., Sonneveld, P., van de Donk, N. W. C. J., Nasserinejad, K., Blommestein, H. M., Cucchi, D. G. J. & Zweegman, S., 1 Aug 2024, In: European Journal of Cancer. 207, 114153.

Research output: Contribution to journal › Article › Academic › peer-review